New diabetes medicines funded: empagliflozin and dulaglutide

Sodium-glucose co-transporter 2 (SGLT-2) inhibitors and glucagon-like...

Prescribing ACE inhibitors: time to reconsider old habits

Prescribers in New Zealand are highly reliant on cilazapril...

News Update: cilazapril with hydrochlorothiazide will no longer be available in New Zealand

Patients currently prescribed cilazapril + hydrochlorothiazide...

Biosimilars: the future of prescribing biological medicines

Biological medicines are an important advancement in the pharmaceutical...

News update: Criteria widened for exceptional circumstances funding of lamotrigine

The funded brand of lamotrigine is changing

Changes in funded brands of antiepileptic medicines can lead...

Antiarrhythmic medicine brand changes: flecainide and amiodarone

Patients taking oral flecainide or amiodarone need to know that...

Vildagliptin: a new treatment for type 2 diabetes

Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor available...

Aripiprazole prescribing changes: Special Authority approval no longer required, new sole-subsidised brand

From 1 June, 2018, aripiprazole can be prescribed without Special...

Prescribing gabapentin and pregabalin: upcoming subsidy changes

From 1 May, 2018, pregabalin will be available to prescribe,...

Methylnaltrexone is a subsidised treatment option for opioid-induced constipation in palliative care

Methylnaltrexone injections are now subsidised for the treatment...

Intravenous ferric carboxymaltose: now available for the treatment of iron deficiency

Intravenous ferric carboxymaltose is now a potential option...

4% dimethicone lotion: a subsidised treatment for head lice

From 1 May, 2017, 4% dimethicone lotion can be prescribed fully...

Access to HPV vaccine widened

The human papillomavirus virus (HPV) vaccine reduces the incidence...

Medicine updates

This article has been archived. If you would like access...

News Updates

This article has been archived. If you would like access...

Atypical antipsychotics: one fully subsidised brand for quetiapine, risperidone and olanzapine

This article has been archived. If you would like access...

Gout update: Febuxostat now subsidised on Special Authority

This article has been archived. If you would like access...

Fluoxetine brand change: Arrow-Fluoxetine sole subsidised brand from 1 July

This article has been archived. If you would like access...

Changes to the National Immunisation Schedule: rotavirus vaccine now added

This article has been archived. If you would like access...

News Updates

This article has been archived. If you would like access...

Risedronate now fully subsidised: What is its place in practice?

This article has been archived. If you would like access...

Ticagrelor – out with the old, in with the new?

Ticagrelor (Brilinta) is a new oral antiplatelet medicine, which...

Upfront: Unapproved medicines and unapproved uses of medicines: keeping prescribers and patients safe

An approved medicine is a medicine which has been through a...

An update on the management of gout

This article has been archived. If you would like access...

News and updates: Update on azithromycin

This article has been archived. If you would like access...

Funding changes to diabetes management products announced

This article has been archived. If you would like access...

Schedule changes for asthma inhalers

This article has been archived. If you would like access...

News in brief: Varenicline: amendments to Special Authority funding

This article has been archived. If you would like access...

News in brief

This article has been archived. If you would like access...

Snippets: Fentanyl patches

This article has been archived. If you would like access...

Snippets: Jadelle & Sibutramine

This article has been archived. If you would like access...

Snippets: Insulin glargine & Ezetimibe

This article has been archived. If you would like access...

Access to clopidogrel now widened

This article has been archived. If you would like access...

Snippets: Iodine supplements Zoledronic acid & Atorvastatin

This article has been archived. If you would like access...

The pharmacological management of Alzheimer’s disease: The place of donepezil

From November 1, 2010 donepezil will be funded without Special...

Practice snippets

This article has been archived. If you would like access...

Nicotine replacement therapy prescription changes

This article has been archived. If you would like access...

Snippets: Nicotinic acid Fosamax Plus & Genetic testing

Nicotinic acid/laropiprant (Tredaptive) ▪ Fosamax Plus...

Are whānau paying the right amount for pharmaceuticals and health services?

This article has been archived. If you would like access...

How does PHARMAC assess if a brand change is appropriate

PHARMAC carefully considers whether brand changes for specific...

Accessing funded medicines in New Zealand

This article has been archived. If you would like access...

Removal of isotretinoin prescriber restrictions

This article has been archived. If you would like access...

Snippets: Anticonvulsants & Salbutamol

This article has been archived. If you would like access...

Brand change update: Ritalin SR now available by special access

This article has been archived; for a copy of the original,...

Upfront: Changing to a Generic Drug

Visits the main points around changing to a generic drug from...

Counselling patients through a brand change

Advice on counselling patients through a brand change.